Response to letter re: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression

被引：0

作者：

Ochi, Nobuaki ^{[1
]}

Ichihara, Eiki ^{[2
]}

Takigawa, Nagio ^{[1
]}

Harada, Daijiro ^{[3
]}

Inoue, Koji ^{[4
]}

Shibayama, Takuo ^{[3
,5
]}

Hosokawa, Shinobu ^{[6
]}

Kishino, Daizo ^{[7
]}

Harita, Shingo ^{[8
]}

Oda, Naohiro ^{[9
]}

Hara, Naofumi ^{[10
]}

Hotta, Katsuyuki ^{[11
]}

Maeda, Yoshinobu ^{[10
]}

Kiura, Katsuyuki ^{[2
]}

机构：

[1] Kawasaki Med Sch, Dept Gen Internal Med 4, Okayama, Japan

[2] Okayama Univ Hosp, Dept Allergy & Resp Med, Okayama, Japan

[3] Natl Hosp Org Shikoku Canc Ctr, Dept Thorac Oncol, Shikoku, Ehime, Japan

[4] Ehime Prefectural Cent Hosp, Dept Resp Med, Matsuyama, Ehime, Japan

[5] Natl Hosp Org Okayama Med Ctr, Dept Resp Med, Okayama, Japan

[6] Japanese Red Cross Okayama Hosp, Dept Resp Med, Okayama, Japan

[7] Himeji Red Cross Hosp, Dept Resp Med, Himeji, Hyogo, Japan

[8] Okayama Saiseikai Gen Hosp, Dept Internal Med, Okayama, Japan

[9] Fukuyama City Hosp, Dept Resp Med, Fukuyama, Hiroshima, Japan

[10] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama, Japan

[11] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan

来源：

EUROPEAN JOURNAL OF CANCER | 2021年 / 157卷

关键词：

D O I：

10.1016/j.ejca.2021.07.044

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：523 / 524

页数：2

共 50 条

[1] Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression
Leonetti, Alessandro
Giudice, Giulia C.
Perrone, Fabiana
Tiseo, Marcello
Giovannetti, Elisa
EUROPEAN JOURNAL OF CANCER, 2021, 157 : 520 - 522
[2] The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer differ based on PD-L1 expression
Ochi, Nobuaki
Ichihara, Eiki
Takigawa, Nagio
Harada, Daijiro
Inoue, Koji
Shibayama, Takuo
Hosokawa, Shinobu
Kishino, Daizo
Harita, Shingo
Oda, Naohiro
Hara, Naofumi
Hotta, Katsuyuki
Maeda, Yoshinobu
Kiura, Katsuyuki
EUROPEAN JOURNAL OF CANCER, 2021, 149 : 73 - 81
[3] DYNAMIC CHANGE OF PD-L1 EXPRESSION ON EXTRACELLULAR VESICLES PREDICTS RESPONSE TO IMMUNE-CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER PATIENTS
Perez, Diego de Miguel
Russo, Alessandro
Gunasekaran, Muthukumar
Cardona, Andres
Lapidus, Rena
Cooper, Brandon
Kaushal, Sunjay
Peterson, Christine
Colen, Rivka
Naing, Aung
Adamo, Vincenzo
Rolfo, Christian
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A17 - A18
[4] Efficacy of immune checkpoint inhibitors according to PD-L1 tumor proportion scores in non-small cell lung cancer
Park, Seongho
Choi, Yoo-Duk
Kim, Jieun
Kho, Bo-Gun
Park, Cheol-Kyu
Oh, In-Jae
Kim, Young-Chul
THORACIC CANCER, 2020, 11 (02) : 408 - 414
[5] VALIDATION OF PD-L1 DYNAMIC EXPRESSION ON EXTRACELLULAR VESICLES AS A PREDICTOR OF RESPONSE TO IMMUNE-CHECKPOINT INHIBITORS AND SURVIVAL IN NON-SMALL CELL LUNG CANCER PATIENTS
de Miguel Perez, Diego
Barron, Feliciano
Russo, Alessandro
Lara-Mejia, Luis
Gunasekaran, Muthukumar
Cardona, Andres
Peterson, Christine
Colen, Rivka
Naing, Aung
Mack, Philip
Hirsch, Fred
Adamo, Vincenzo
Arrieta, Oscar
Rolfo, Christian
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A25 - A26
[6] Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
de Miguel-Perez, Diego
Russo, Alessandro
Arrieta, Oscar
Ak, Murat
Barron, Feliciano
Gunasekaran, Muthukumar
Mamindla, Priyadarshini
Lara-Mejia, Luis
Peterson, Christine B.
Er, Mehmet E.
Peddagangireddy, Vishal
Buemi, Francesco
Cooper, Brandon
Manca, Paolo
Lapidus, Rena G.
Hsia, Ru-Ching
Cardona, Andres F.
Naing, Aung
Kaushal, Sunjay
Hirsch, Fred R.
Mack, Philip C.
Serrano, Maria Jose
Adamo, Vincenzo
Colen, Rivka R.
Rolfo, Christian
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
[7] Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
Diego de Miguel-Perez
Alessandro Russo
Oscar Arrieta
Murat Ak
Feliciano Barron
Muthukumar Gunasekaran
Priyadarshini Mamindla
Luis Lara-Mejia
Christine B. Peterson
Mehmet E. Er
Vishal Peddagangireddy
Francesco Buemi
Brandon Cooper
Paolo Manca
Rena G. Lapidus
Ru-Ching Hsia
Andres F. Cardona
Aung Naing
Sunjay Kaushal
Fred R. Hirsch
Philip C. Mack
Maria Jose Serrano
Vincenzo Adamo
Rivka R. Colen
Christian Rolfo
Journal of Experimental & Clinical Cancer Research, 41
[8] Impact of Corticosteroids and Antibiotics on Efficacy of Immune-Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Riudavets, M.
Mosquera, J.
Garcia Campelo, R.
Serra, J.
Anguera, G.
Gallardo, P.
Sullivan, I. G.
Barba, A.
Majem, M.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S728 - S728
[9] Investigation of response factors for monotherapy with immune checkpoint inhibitors in non-small cell lung cancer patients with PD-L1 expression <50%
Takahara, Yutaka
Abe, Ryudai
Sumito, Nagae
Tanaka, Takuya
Ishige, Yoko
Shionoya, Ikuyo
Yamamura, Kouichi
Nishiki, Kazuaki
Nojiri, Masafumi
Kato, Ryo
Shinomiya, Shohei
Oikawa, Taku
THORACIC CANCER, 2023, 14 (27) : 2754 - 2760
[10] Impact of corticosteroids and antibiotics on efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer
Mosquera Martinez, J.
Riuvadets, M.
Garcia-Campelo, M-R.
Serra Lopez, J.
Anguera Palacios, G.
Gallardo Melo, P.
Sullivan, I.
Barba Joaquin, A.
Majem Tarruella, M.
Reboredo Rendo, C.
Cordeiro Gonzalez, P.
ANNALS OF ONCOLOGY, 2019, 30

← 1 2 3 4 5 →